JPRN-UMIN000006674已完成2 期
A Phase II study of neoadjuvant combination chemotherapy with TS-1, cisplatin and Paclitaxel (PCS) for resectable advanced gastric cancer. - NECESSIT study
Kinki University Faculty of Medicine0 个研究点目标入组 20 人开始时间: 2011年11月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) With severe allergy to TS-1, Cisplatin and Paclitaxel 2) Women who are pregnant or breastfeeding. 3) Men who are unwilling to avoid pregnancy. 4) Active infection and inflammation. 5) History of cardiac disease 6) Dyspnea at rest
研究者
相似试验
进行中（未招募）
1 期
Phase Ib/II study assessing the neo-adjuvant combination therapy of vinflunine with cisplatin followed by radical cystectomy in patients with muscle-invasive bladder cancerEUCTR2016-000081-33-DEigartis GmbH42
招募中
2 期
PhaseII Study of Neoadjuvant and adjuvant Chemotherapy with Pemetrexed/Carboplatin/Bevacizumab in patients with non-squamouns non Small-cell lung canceron-Squamouns Non-small-cell-lung-cancerJPRN-UMIN000009032Kansai Medical University Hirakata Hospital35
已完成
2 期
A Phase II Study of Neo-adjuvant Combination Therapy of Trastuzumab and Anastrozole for Hormone Receptor-Positive, HER2-Positive Postmenopausal Breast Cancer(WJOG7412B)Hormone receptor-positive, HER2-positive postmenopausal breast cancerJPRN-UMIN000011023West Japan Oncology Group70
已完成
2 期
Phase II trial of neoadjuvant combination chemotherapy with gemcitabine and S-1 for locally advanced pancreatic cancerlocally advanced pancreatic cancerJPRN-UMIN000001450Faculty of Medicine, Kyoto University35
已完成
2 期
A phase II trial of Neoadjuvant and adjuvant chemotherapy with Gemcitabine and TS-1 combination for patients with locally advanced pancreatic cancerpancreatic cancerJPRN-UMIN000005578Chiba study group of adjuvant chemotherapy for pancreatic cancer45